$7 million grant renewal supports cancer drug discovery research based on compounds found in nature

COLUMBUS, Ohio -The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and the Ohio State College of Pharmacy have been awarded a five-year, $7 million competitive Program Project Grant (PPG) grant renewal from the National Cancer Institute (NCI). This multidisciplinary project grant…

Details

Research could change how blood pressure is managed in spinal cord injury patients

New research from the International Collaboration on Repair Discoveries (ICORD) challenges the current standard for managing blood pressure in people with spinal cord injury (SCI). The findings, published today in Nature Communications, could lead to a change in the way newly injured patients have their blood pressure managed, potentially improving their chances of retaining more…

Details

Start-up awarded grant to develop contrast agent for early detection of liver disease

ATLANTA–Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Institute of Health grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis, formation of scar tissue in the liver caused by alcoholic and non-alcoholic fatty liver…

Details

Conquering CHD, Children’s Hospital Colorado encourage others to provide cardiac outcomes

Aurora, Colo. (Oct. 15, 2020) – Congenital Heart Disease (CHD) is the most common birth defect in the United States, occurring in approximately one in every 100 babies. However, hospital data regarding short- and long-term outcomes for patients has been limited and oftentimes difficult to access and/or interpret. “Children’s Hospital Colorado has long been committed…

Details

New bioprosthetic valve for TAVR fails to demonstrate non-inferiority

NEW YORK – October 15, 2020 – In a randomized clinical trial, SCOPE II, a new self-expanding bioprosthetic valve used in transcatheter aortic valve replacement (TAVR) failed to demonstrate non-inferiority compared to an existing self-expanding valve. Findings were reported today at TCT Connect, the 32nd annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT…

Details

Results from the MITHRAS trial reported at TCT Connect and published in Circulation

NEW YORK – October 15, 2020 – The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative medical treatment with regard to the primary endpoint of change in six-minute walking distance. Findings were reported today at TCT…

Details

ISSCR’s stem cell based clinical trials guide recognized by Tech Spotlight

Skokie, IL–The ISSCR’s Stem Cell-Based Clinical Trials: Practical Advice for Physicians and Ethics/Institutional Review Committees was honored today by Tech Spotlight at Harvard Kennedy School’s Belfer Center. Tech Spotlight recognizes the technologists, activists, and policymakers who are thoughtfully creating and using technology in ways to protect the public good and help shape a better future.…

Details